Owners, management and financials
CVR: 40560866
DKK -154,862
Gross profit
Net result: DKK -129,437
Benjamin Anderschou Holbech Jensen (15-19,99%), PN INVESTMENT ApS (33,33-49,99%)
1 more
CVR · view owners
Benjamin Anderschou Holbech Jensen
Board: Peter Hviid Nordkild (chair) and 1 member
CVR · view management
Active
Founded 14 May 2019
CVR · view overview
No headcount reported
Owner registered: Benjamin Anderschou Holbech Jensen
CVR · 08/09/2022
View the full event history
Aesculus Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Benjamin Anderschou Holbech Jensen. The board consists of Peter Hviid Nordkild (chair) and Benjamin Anderschou Holbech Jensen. The company is owned by Benjamin Anderschou Holbech Jensen, PN INVESTMENT ApS and Jan Wehkamp. In 2025, the company reported a gross profit of DKK -154,862 and a net result of DKK -129,437 compared with DKK -45,866 the year before. Equity in the 2025 report amounted to DKK -34,097.
Selskabets formål er at drive forskning og udvikling rettet mod udvikling af medicinske produkter, som kan regulere microbiota og dermed relaterede sygdomme, og andre hermed relaterede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -155 t. | -129 t. | 309 t. | -34 t. | - | |
| 202401/01/2024 – 31/12/2024 | -50 t. | -46 t. | 228 t. | 95 t. | - | |
| 202301/01/2023 – 31/12/2023 | -14 t. | -11 t. | 270 t. | 141 t. | - | |
| 202201/01/2022 – 31/12/2022 | -25 t. | -15 t. | 300 t. | 152 t. | - | |
| 202101/01/2021 – 31/12/2021 | 88 t. | 74 t. | 408 t. | 167 t. | - | |
| 202001/01/2020 – 31/12/2020 | -12 t. | -15 t. | 207 t. | 93 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Aesculus Bio ApS is 40560866.
Aesculus Bio ApS is owned by Benjamin Anderschou Holbech Jensen, PN INVESTMENT ApS and Jan Wehkamp.
The management of Aesculus Bio ApS consists of Benjamin Anderschou Holbech Jensen.
The board of Aesculus Bio ApS consists of Peter Hviid Nordkild and Benjamin Anderschou Holbech Jensen, with Peter Hviid Nordkild as chair.
In 2025, Aesculus Bio ApS reported a gross profit of DKK -154,862.
Aesculus Bio ApS was founded on 14 May 2019.
Claim this page to add your logo and social links. Free to get started.
Aesculus Bio ApS has published its annual report for 2025. Gross profit came to DKK -154,862, and the net result was DKK -129,437.
Aesculus Bio ApS has published its annual report for 2024. Gross profit came to DKK -49,785, and the net result was DKK -45,866.
Aesculus Bio ApS has published its annual report for 2023. Gross profit came to DKK -13,631, and the net result was DKK -10,881.
Aesculus Bio ApS has published its annual report for 2022. Gross profit came to DKK -25,019, and the net result was DKK -14,524.
As of September 8, 2022, Benjamin Anderschou Holbech Jensen is registered as an owner of Aesculus Bio ApS with an ownership share of 15%.
Aesculus Bio ApS has published its annual report for 2021. Gross profit came to DKK 87,677, and the net result was DKK 73,545.
Aesculus Bio ApS has published its annual report for 2020. Gross profit came to DKK -11,740, and the net result was DKK -14,631.
Aesculus Bio ApS has published its interim report for the period May 14, 2019 to December 31, 2019.
As of April 18, 2020, PN INVESTMENT ApS is registered as an owner of Aesculus Bio ApS with an ownership share of 33%.
As of May 14, 2019, Benjamin Anderschou Holbech Jensen has joined the board of directors of Aesculus Bio ApS.
As of May 14, 2019, Peter Hviid Nordkild has joined the board of directors of Aesculus Bio ApS.
As of May 14, 2019, Benjamin Anderschou Holbech Jensen is registered as adm. dir. of Aesculus Bio ApS.
As of May 14, 2019, is registered as an owner of Aesculus Bio ApS with an ownership share of 33%.
Aesculus Bio ApS was founded on May 14, 2019.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 29418888
CVR 29769796
CVR 34688605
CVR 34892970
CVR 35047565
